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Alternative treatments such as spiritual healing and prayer are increasingly popular, especially among patients with life-threatening
diseases such as cancer. According to theories of spiritual healing, this intervention is thought to influence living cells and organisms
independently of the recipient’s conscious awareness of the healer’s intention. The aim of this study was to test the hypothesis that
spiritual healing will reduce proliferation and viability of two cancer cell lines in vitro. Three controlled experiments were conducted
with three different healers and randomised allocation of cells to five different doses of healing or control. Researchers conducting the
assays and statistical analyses were blinded to the experimental conditions. Main outcome measures were MTT viability,
3H-thymidine
incorporation and counts of an adherent human breast cancer cell line (MCF-7), and a nonadherent mouse B-lymphoid cell line (HB-
94). Analyses of variance (ANOVAs) revealed no significant main or dose-related effects of spiritual healing compared to controls for
either of the two cell lines or any of the assays (P-values between 0.09 and 0.96). When comparing healing and control across all
three experimental days, doses, assays, and cells, 34 (51.6%) of 66 independent comparisons showed differences in the hypothesised
direction (P¼0.90). The average effect size across cell lines, days, assays, and doses approached zero (Cohen’s d¼ 0.01). The
results do not support previous reports of beneficial effects of spiritual healing on malignant cell growth in vitro. Reported beneficial
effects of spiritual healing on the well-being of cancer patients seem more likely to be mediated by psychosocial and
psychophysiological effects of the healer–patient relationship.
British Journal of Cancer (2005) 93, 538–543. doi:10.1038/sj.bjc.6602749 www.bjcancer.com
Published online 23 August 2005
& 2005 Cancer Research UK
Keywords: healing; alternative medicine; MCF-7; HB-94
                                                     
Complementary and alternative medicine (CAM) (National Center
for Alternative and Complementary Medicine, 2004) is increasingly
popular, especially among patients with chronic and life-threaten-
ing diseases such as cancer (Lerner and Kennedy, 1992; Downer
et al, 1994; Boon et al, 2000). Results from a 1999 national health
interview survey of the use of CAM showed that spiritual healing
or prayer was the most frequently used complementary or
alternative treatment (13.7%) by adults in the US (Ni et al,
2002). Spiritual healing has been defined as a systematic,
purposeful intervention by one or more persons aiming to help
another living being (person, animal, plant, cell or other living
system) by means of focused intention to improve their condition
(Benor, 2002). Spiritual healing includes many categories, for
example, ‘therapeutic touch’ and ‘intercessory prayer’, and the
healing may be attributed to God, spirits, universal forces or
energies, biological healing energies residing in the healer, or self-
healing powers or energies thought to reside latent in the healed
organism.
A review suggests that spiritual healing may have beneficial
effects on various human psychological and physical problems
(Benor, 2002). The results, however, are mixed, and the
methodological quality often questionable. A major problem in
interpreting the results of human healing research lies in
controlling for the influence of factors other than the hypothesised
specific effect of spiritual healing, defined as influencing at a
‘distance’, through ‘nonlocal consciousness’ independently of the
recipients awareness of the healers intention. Such other factors
may include ‘nonspecific’ effects (Frank, 1973) of beliefs, expecta-
tion, and other psychological aspects of the healer–patient
relationship. Such confounders are not an issue in experiments
carried out in vitro, and results from experiments studying the
effects of spiritual healing on bacteria (Nash, 1982), yeasts
(Haraldsson and Thorsteinsson, 1973), microorganisms (Pleass
and Dey, 2005), or human cells in the laboratory (Braud, 1990)
have been published. While the majority of these reports show
positive results, replications are rare.
A search of the literature revealed three studies of effects of
healing on malignant cells in vitro. Chen and He (2001) reported
significantly reduced PPT-I expression in breast cancer cells
following Qigong, a Chinese form of healing. Shah et al (1999)
reported moderate effects of healing in the expected direction, that
is, reduced cell counts, for four different tumour cell lines. Finally,
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sin an early study, Snel (1980) investigated the effect of healing on
growth of mouse leukaemia cells in vitro. One of three experiments
yielded results in the expected direction. The few available results
do not allow for a clear conclusion. Although other studies have
been conducted over the last 15 years, the results are only available
as abstracts from conference proceedings or unpublished pre-
liminary reports.
The highly controversial hypothesised effects of distant or
spiritual healing contradict our ordinary sense of reality, are in
conflict with the generally agreed upon laws of science, and only
the results of independent, well-controlled experimental studies
can clarify the issue. The aim of our study was therefore to
investigate the possible inhibiting effects of spiritual healing on cell
counts, viability, and proliferation of two cancer cell lines with
different characteristics: human and animal, adherent and non-
adherent. A human adherent breast cancer cell line was chosen,
since breast cancer represents one of the leading causes of cancer-
related death, and since positive results had previously been
reported for breast cancer cell lines (Shah et al, 1999; Chen and He,
2001). In addition, a nonadherent cell line of mouse origin was
used. Together with cell counting, as investigated in most previous
studies, we included assays measuring two additional aspects of
cell growth.
METHODS
Cell lines and assays
Cell lines Two cell lines were used: (1) MCF-7, an adherent
human breast cancer cell line (Brooks et al, 1973) and (2) HB-94, a
nonadherent mouse B-lymphoid cell line (Brodsky and Parham,
1982) (ATCC, Rockville, MD, USA). Cell viability: The 3-(4,5-
dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
reduction assay (MTT-assay) was used for quantification of viable
cells (Mosmann, 1983). Cell proliferation was measured using a
standard
3H-thymidine incorporation assay. Cell counts were
performed independently in a haemocytometer by two researchers
(BB and LS). The cells were counted and viability and proliferation
assays were conducted the following day, 24h after beginning the
experiment. In the previous studies, incubation periods were 16h
(four breast cancer cell lines) (Chen and He, 2001), 24h (four
different cell lines, including the MCF-7 breast cancer cell line)
(Shah et al, 1999), and 96h (mouse leukaemia cells) (Snel, 1980).
In the latter study, only one of four experiments showed changes in
the expected direction.
Procedure
A total of 12 plates were used in each of three experiments under
identical conditions on three separate days. In all, 10 plates were
randomised to an experimental (healing) or a control group, and
two plates remained in the incubator during the experiment as
additional control. Experimental and control plates were removed
from the incubator and placed in a flow bench for the same
number of minutes with the same time interval in counter-
balanced order. All 10 plates were placed in a flow bench for
10min followed by 50min in the incubator, eight plates for an
additional 10min, six plates for 3 10min, four plates for
4 10min, and two plates for a total of 5 10min, yielding a
design with increasing doses of exposure (10, 20, 30, 40, and
50min) to healing or control over a total of 4h and 10min for each
condition. A total of 504 wells were analysed, making it possible to
compare cells in 2 45 wells across all experimental days and
doses for each cell line and assay. Setting aside a total of 84 wells
for additional control, a total of 2 15 wells were available for cell
counting for each cell line.
Healing
Healing was performed by three healers with 6–18 years of
experience, all reporting themselves as successful in their clinical
work. None had previously worked with biological material. The
healers used their own individual method to attempt to inhibit
viability and growth of the cancer cells. Two thus held their hands
20–30cm over the plates, but none of the healers touched the
plates physically at any time. The sessions were video recorded,
and after the sessions, the healers were interviewed concerning
their experiences during the experiment. The healers were not
present during control sessions.
Blinding
The researchers involved in the analysis of the cell cultures were
blinded with respect to experimental condition and dose. The
statistician (MV) was blinded to the purpose of the study and the
experimental conditions.
Power considerations
Data from the three previous experiments involving malignant cell
cultures showed significant differences between healing and
control corresponding to effect sizes (Cohen’s d (Cohen, 1988))
ranging from  0.5 to þ2.0 (average: þ0.6) (Snel, 1980; Shah et al,
1999; Chen and He, 2001). With the number of plates possible in
our study, simple comparisons across all three experimental days
and all five doses allowed us to detect a difference corresponding
to an effect size of 0.6 with a statistical power of 80% (a: 5%) for
each assay and cell line. Setting aside 84 wells for additional
control cells to be kept in the incubator, a total of 2 15 wells
remained available for cell counting for both cell lines, making it
possible to detect a difference corresponding to an effect size of
1.06 with a statistical power of 80% (a: 5%).
Statistical methods
Analysis of variance (ANOVA) methods were used to analyse the
experimental data. Each cell line was analysed separately for each
of the three assays. Data from the unmanipulated control plates
were not included in these analyses. Non-normally distributed
data were log transformed prior to analysis. The ANOVA used to
analyse MTT viability and
3H-thymidine incorporation was based
on the average of measurements from the three wells and included
main effects of condition (healing and control) and dose (10–
50min), and an interaction between these factors. The effect of
healing was assessed by testing the hypotheses of no interaction
between dose and condition and no main effect of condition. The
experimental design for the cell count experiments was different,
and the analysis here was based on the difference between counts
for the two conditions. The effect of healing was assessed by
testing the hypotheses of no main effect of dose. The main effect of
healing was evaluated by computing a confidence interval for the
overall mean of the differences. In a supplementary analysis, dose
was included as a covariate to assess a linear trend with dose. To
investigate differences between healers these analyses were
supplemented by ANOVAs, which included day (¼healer) and
interactions with day as systematic effects. The statistical package
GenStat Release 7.1 (VSN International Ltd, UK) was used for all
computations. To allow for comparison with previous results,
effect sizes (Cohen’s d) were calculated for the difference between
healing and control for each assay, cell line, and dose, as well as
for the pooled differences across doses for counts for both cell
lines.
(Additional information on assays, procedure and statistical
analyses is available on request to the corresponding author.)
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sRESULTS
The results of the ANOVA of the MTT viability measurements are
summarised in Table 1. Figure 1 shows the average results for each
day, dose, and condition. For the MCF-7 cells, the dependence on
dose did not differ between the two experimental conditions
(P¼0.76), and the overall difference was not statistically
significant (P¼0.35). When dose was included as a covariate,
the linear trend with dose did not differ between the two
experimental conditions (P¼0.41) and no overall trend with dose
was found (P¼0.53). The findings were very similar for the HB-94
cell line. Again, the dose dependence did not depend on
experimental condition (P¼0.73), the overall difference was not
statistically significant (P¼0.53), the trend with dose did not
depend on dose (P¼0.96), and the overall trend was not
statistically different from zero (P¼0.69). For both cell lines, we
found a considerable variation between days/healers (see Figure 1),
but a similar day-to-day variation was also seen for the unexposed
control measurements.
Table 2 gives the corresponding results for
3H-thymidine
incorporation activity, and Figure 2 shows the average activity
for each day, dose, and condition. For both cell lines, the dose
dependence did not differ between the two experimental condi-
tions (MCF-7: P¼0.39, HB-94: P¼0.74), and no statistically
significant, overall difference was found (MCF-7: P¼0.45, HB-94:
P¼0.09). For both cell lines, these conclusions were maintained
when the dose dependence was described by a linear trend. As
found for MTT viability, we found considerable variation between
days/healers for the
3H-thymidine incorporation activity (Figure 2),
and again this variation was also present for the unexposed control
measurements.
Table 3 presents the results of the ANOVA of the cell counts and
Figure 3 shows the average count for each day, dose, and
condition. For both cell lines, the contribution to the total
variation of the variation between doses within days was
statistically significant. The dependence of the differences on dose
was therefore evaluated relative to this random component. The
analysis showed that the effect of dose was not statistically
significant (MCF-7: P¼0.19, HB-94: P¼0.28). When dose was
included as a covariate, no linear trend with dose was seen in the
difference between the two experimental conditions (MCF-7 cells:
P¼0.13, HB-94 cells: P¼0.45). For cell counts, the day-to-day
Table 1 MTT-viability assay
MCF-7 cells HB-94 cells
Source of variation Mean square df F-test P-value Mean square df F-test P-value
Between days 2.196 2 197.01 o0.001 0.570 2 15.98 o0.001
Day by dose stratum
Dose 0.020 4 1.83 0.217 0.004 4 0.11 0.976
Residual 0.011 8 1.14 0.036 8 3.01
Day by dose by condition stratum
Condition 0.009 1 0.97 0.349 0.005 1 0.43 0.526
Condition dose 0.005 4 0.46 0.762 0.006 4 0.51 0.732
Residual 0.010 10 0.012 10
Analysis of variance of average readings.
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Figure 1 Average MTT-viability measurements (counts per ml) by day, condition, and dose (10–50min). Left panel shows results for MCF-7 cells, right
panel shows results for HB-94 cells. Experimental units, which received healing, are shown with filled symbols, control units with open symbols. Symbols:
Square for day 1, circle for day 2, and triangle for day 3. Dose ‘0’ represents additional controls remaining in the incubator.
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svariation was less striking, but also present in the unexposed
control measurements.
Finally, standardised differences between healing and control,
that is, effect sizes (Cohen’s d) (Cohen, 1988), were calculated for
each of 66 possible independent comparisons across days
(healers), cell lines, assays, doses, and cell lines (data not shown,
but available on request to the corresponding author). Of 66
independent comparisons, 34 (51.6%) yielded results in the
expected direction, corresponding to a probability of 0.90 (two-
tailed). The per cent differences in the expected direction for each
of the 3 days were 50% (Day 1), 55% (Day 2), and 55% (Day 3),
with the corresponding probabilities of 1.00, 0.83, and 0.83. The
average effect size across all cell lines, days, assays, and doses
approached zero (d¼ 0.01).
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Figure 2 Average
3H-thymidine incorporation activity (counts per ml) by day, condition, and dose (10–50min). Left panel shows results for MCF-7 cells,
right panel shows results for HB-94 cells. Experimental units, which received healing, are shown with filled symbols, control units with open symbols. Symbols:
square for day 1, circle for day 2, and triangle for day 3. Dose ‘0’ represents additional controls remaining in the incubator.
Table 3 Cell counts
MCF-7 cells HB-94 cells
Source of variation Mean square df F-test P-value Mean square df F-test P-value
Between days 0.029 2 9.32 0.004 0.002 2 0.30 0.746
Between persons 0.013 1 8.96 0.011 0.019 1 2.30 0.155
Days by person stratum 0.001 2 0.48 0.630 0.008 2 1.04 0.384
Day by dose stratum
Dose 0.046 4 2.01 0.186 0.101 4 1.56 0.275
Residual 0.023 8 7.43 0.001 0.065 8 7.91 0.001
Day by person by dose stratum 0.003 12 0.008 12
Analysis of variance of differences between log-transformed counts.
Table 2
3H-thymidine incorporation assay
MCF-7 cells HB-94 cells
Source of variation Mean square df F-test P-value Mean square df F-test P-value
Between days 9.185 2 192.86 o0.001 28.451 2 553.94 o0.001
Day by dose stratum
Dose 0.090 4 1.9 0.204 0.010 4 0.2 0.934
Residual 0.048 8 1.53 0.260 0.051 8 0.98 0.502
Day by dose by condition stratum
Condition 0.019 1 0.63 0.447 0.178 1 3.41 0.094
Condition dose 0.036 4 1.15 0.390 0.026 4 0.5 0.736
Residual 0.031 10 0.052 10
Analysis of variance of average log-transformed activity.
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identified (data not shown, details concerning raw data available
on request), representing a total data loss of less than 1%.
DISCUSSION
This study did not reveal any significant main or dose-related
effect of spiritual healing on proliferation and viability of either of
two cancer cell lines. While there was considerable variability
between days, there were no differences between days in the dose-
dependent effects of healing and control. Across cell lines,
experimental days, assays, and doses, an almost equal number of
differences were in the hypothesised (51.6%) and the opposite of
the hypothesised direction (48.4%). Our results differ from those
of three previous experimental studies of healing and cancer cells
in vitro (Snel, 1980; Shah et al, 1999; Chen and He, 2001).
Strengths and weaknesses
A systematic review of published healing research (Crawford et al,
2003) indicates that many studies fail to fulfil important quality
criteria, including (a) adequate control, (b) randomisation, (c)
baseline comparability, (d) blinding, (e) acceptable loss of data, (f)
clear description of intervention, (g) outcome measures, (h)
adequate statistical analysis, and (i) reproducibility. In the present
study, all the above criteria were met. In addition to control cells
being handled similarly to the cells exposed to healing, that is,
moving the cells from and back to the incubator, additional
controls remained in the incubator. These additional controls
(dose ‘0’) did not differ from cells in the intervention and control
group. Special care was taken in blinding not only the researchers
conducting the biological assays but also the statistician. Data loss
was minimal, and reproducibility was met by conducting three
separate experiments with three different healers under identical
conditions, using two cell lines and three biological indicators of
cell proliferation and viability. In contrast to previous studies
(Snel, 1980; Shah et al, 1999; Chen and He, 2001), increasing doses
of healing were included, enabling detection of a possible dose-
dependent relationship. Still, the large number of wells yielded
adequate statistical power to detect differences across doses similar
to or smaller than those found in the previous studies.
One explanation for our negative findings could be that the
doses used (10–50min) were inadequate. They were, however,
generally not smaller than those used in previous studies reporting
significant effects of spiritual healing. For example, in one study
with reported effects on malignant cell growth, the healing dose
was reported as 20min (Shah et al, 1999), and in a study reporting
effects of healing on cytotoxic activity of natural killer cells doses
were from 30s to 5min (Lee et al, 2001). The healers used the
healing method of their own choice, and two of the healers chose
to hold their hands approx. 20–30cm over the plates, while the
third healer did not. This could theoretically be a cause of concern.
It has been proposed that healing effects could be due to
electromagnetic fields (Seto et al, 1992) or infrared radiation
(Chien et al, 1991) emitted from the hands of the healer. However,
in spite of considerable day-to-day variation, we found no
differences in the effects of healing across healers. Also, the
additional controls remaining in the incubator showed similar
variation, indicating that this was due to factors other than the
intervention.
It is theoretically possible that the effects of healing could be
transient or delayed, and that positive results would have been
found if other incubation periods had been used. However, the
incubation period used (24h) was similar to the ones used in
previous studies reporting effects of healing on malignant cells in
culture (16–24h). Moreover, if our negative results were a result of
too extensive or insufficient timing, we should expect at least some
indication of an effect in the expected direction. This was clearly
not the case.
In addition to conventional methodological issues, other specific
issues may be relevant for healing research (Schlitz et al, 2003).
Since ‘healing intention’ is a key element in spiritual healing, a
positive result may require that the healer has both the desire to
heal and the belief and skill necessary to perform the healing.
When interviewed after the experiment, the healers generally
reported no concerns regarding their intention, desire, or skills.
Finally, it could still be argued that the mere fact that an
experiment was conducted could limit the ability of the healers.
Informed of the negative result, one healer involved thus suggested
that a ‘selfish intention to prove that healing works’ differs from
the true altruistic ‘intention to heal’, and that only the latter should
be expected to show results. Also, it should be noted that tumour
cells differ in their characteristics, and it is possible that some cell
types are more susceptible to healing than others.
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Figure 3 Average cell count per ml by day, condition, and dose (10–50min). Left panel shows results for MCF-7 cells, right panel shows results for HB-94
cells. Experimental units, which received healing, are shown with filled symbols, control units with open symbols. Symbols: square for day 1, circle for day 2,
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sCONCLUSIONS
While agreeing that psychological aspects are a part of healing in
the human setting, proponents of spiritual healing stress that
effects are due to mechanisms beyond conventional pharmacolo-
gical, physiological and psychological factors, and that healing can
be performed ‘at a distance’ without conscious awareness on the
part of the recipient, which can be any living being (person,
animal, plant, cell, or other living system) (Benor, 2002). However,
in the present tightly controlled study there was no evidence of
such an effect for the cell lines investigated. The theory of spiritual
healing is highly controversial and in conflict with the generally
agreed upon laws of science. While this could explain why spiritual
healing and other nonconventional methods are rarely investi-
gated, the lack of scientific research will continue to leave the
proposed mechanisms and effects of such interventions generally
unchallenged.
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